Open Access. Powered by Scholars. Published by Universities.®

Physical Sciences and Mathematics Commons

Open Access. Powered by Scholars. Published by Universities.®

Chemistry Faculty Publications

2015

CSUOH0901; nimesulide; LC-MS/MS; protein precipitation; rat plasma

Articles 1 - 2 of 2

Full-Text Articles in Physical Sciences and Mathematics

A Rapid Lc-Ms/Ms Method For Quantification Of Csuoh0901, A Novel Antitumor Agent, In Rat Plasma, Ramakrishna R. Voggu, Ravali Alagandula, Xiang Zhou, Bin Su Ph.D., Bo Zhong, Baochuan Guo May 2015

A Rapid Lc-Ms/Ms Method For Quantification Of Csuoh0901, A Novel Antitumor Agent, In Rat Plasma, Ramakrishna R. Voggu, Ravali Alagandula, Xiang Zhou, Bin Su Ph.D., Bo Zhong, Baochuan Guo

Chemistry Faculty Publications

CSUOH0901, a novel anticancer derivative of nimesulide, exhibits very promising anticancer activities in various cancer cell lines. In order to support further pharmacological and toxicological studies of this promising anticancer drug candidate, an LC-MS/MS method was developed and validated in accordance with the US Food and Drug Administration guidelines. The drug molecules were extracted from plasma samples by protein precipitation and then analyzed with LC-ESI-MS/MS. An excellent analyte separation was achieved using a phenomenex C18 column with a mobile phase of 90% methanol and 5 m m of ammonium formate. The validated linear dynamic range was between 0.5 and 100 …


A Rapid Lc-Ms/Ms Method For Quantification Of Csuoh0901, A Novel Antitumor Agent, In Rat Plasma, Ramakrishna R. Voggu, Ravali Alagandula, Xiang Zhou, Bin Su, Bo Zhong, Baochuan Guo May 2015

A Rapid Lc-Ms/Ms Method For Quantification Of Csuoh0901, A Novel Antitumor Agent, In Rat Plasma, Ramakrishna R. Voggu, Ravali Alagandula, Xiang Zhou, Bin Su, Bo Zhong, Baochuan Guo

Chemistry Faculty Publications

CSUOH0901, a novel anticancer derivative of nimesulide, exhibits very promising anticancer activities in various cancer cell lines. In order to support further pharmacological and toxicological studies of this promising anticancer drug candidate, an LC-MS/MS method was developed and validated in accordance with the US Food and Drug Administration guidelines. The drug molecules were extracted from plasma samples by protein precipitation and then analyzed with LC-ESI-MS/MS. An excellent analyte separation was achieved using a phenomenex C18 column with a mobile phase of 90% methanol and 5 m m of ammonium formate. The validated linear dynamic range was between 0.5 and 100 …